StageZero Life Sciences Ltd. (SZLSF)
OTCMKTS
· Delayed Price · Currency is USD
0.0240
-0.0024 (-9.27%)
Jun 25, 2025, 3:14 PM EDT
StageZero Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2013 - 2017 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2013 - 2017 |
Cash & Equivalents | 0.02 | 0.02 | 1.72 | 6.6 | 0.07 | 0.11 | Upgrade
|
Cash & Short-Term Investments | 0.02 | 0.02 | 1.72 | 6.6 | 0.07 | 0.11 | Upgrade
|
Cash Growth | -27.55% | -99.09% | -73.86% | 9175.61% | -33.05% | 157.69% | Upgrade
|
Accounts Receivable | 0.08 | 0.03 | 0.13 | 0.07 | - | - | Upgrade
|
Other Receivables | - | - | - | 0.1 | 0.17 | 0.05 | Upgrade
|
Receivables | 0.08 | 0.03 | 0.13 | 0.17 | 0.17 | 0.05 | Upgrade
|
Inventory | 0.02 | 0.1 | 0.41 | 0.35 | 0.09 | 0.11 | Upgrade
|
Prepaid Expenses | 0.17 | 0.12 | 0.12 | 0.1 | 0.05 | 0.09 | Upgrade
|
Total Current Assets | 0.29 | 0.27 | 2.39 | 7.22 | 0.38 | 0.35 | Upgrade
|
Property, Plant & Equipment | 0.21 | 0.43 | 0.87 | 1.26 | 1.04 | 1.07 | Upgrade
|
Goodwill | - | - | 7.36 | - | - | - | Upgrade
|
Other Long-Term Assets | - | - | 0.03 | 0.03 | 0.54 | 0.03 | Upgrade
|
Total Assets | 0.51 | 0.7 | 10.65 | 8.51 | 1.96 | 1.45 | Upgrade
|
Accounts Payable | 3.67 | 2.82 | 0.73 | 1.25 | 1.35 | 2.03 | Upgrade
|
Accrued Expenses | 3.77 | 2.65 | 1.34 | 1.27 | 1.49 | 1.27 | Upgrade
|
Short-Term Debt | 0.5 | 0.84 | 0.24 | 2.27 | 0.68 | 1.16 | Upgrade
|
Current Portion of Long-Term Debt | 0.12 | 0.19 | 0.12 | 0.12 | 0.45 | 0.74 | Upgrade
|
Current Portion of Leases | - | 0.19 | 0.22 | 0.18 | 0.15 | - | Upgrade
|
Current Unearned Revenue | 0.01 | 0.07 | 0.2 | 0.22 | - | - | Upgrade
|
Other Current Liabilities | 0.21 | 0.26 | 1.9 | 0.23 | 0.09 | 0.3 | Upgrade
|
Total Current Liabilities | 8.27 | 7.03 | 4.74 | 5.56 | 4.22 | 5.52 | Upgrade
|
Long-Term Debt | 0.74 | 0.58 | 0.58 | 0.58 | 0.57 | 0.95 | Upgrade
|
Long-Term Leases | - | - | 0.19 | 0.42 | 0.6 | - | Upgrade
|
Other Long-Term Liabilities | 0.57 | 0.6 | 2.36 | 3.19 | 1.06 | 0.49 | Upgrade
|
Total Liabilities | 9.58 | 8.2 | 7.88 | 9.74 | 6.46 | 6.96 | Upgrade
|
Common Stock | 102.44 | 101.39 | 100.52 | 89.33 | 80.28 | 76.82 | Upgrade
|
Additional Paid-In Capital | 13.3 | 12.91 | 12.56 | 12.27 | 11.2 | 10.46 | Upgrade
|
Retained Earnings | -126.05 | -123.04 | -111.62 | -104.14 | -97.28 | -94.09 | Upgrade
|
Comprehensive Income & Other | 1.23 | 1.23 | 1.31 | 1.3 | 1.3 | 1.3 | Upgrade
|
Shareholders' Equity | -9.07 | -7.5 | 2.76 | -1.23 | -4.49 | -5.51 | Upgrade
|
Total Liabilities & Equity | 0.51 | 0.7 | 10.65 | 8.51 | 1.96 | 1.45 | Upgrade
|
Total Debt | 1.36 | 1.8 | 1.36 | 3.57 | 2.46 | 2.86 | Upgrade
|
Net Cash (Debt) | -1.33 | -1.78 | 0.37 | 3.03 | -2.39 | -2.75 | Upgrade
|
Net Cash Growth | - | - | -87.83% | - | - | - | Upgrade
|
Net Cash Per Share | -0.01 | -0.02 | 0.01 | 0.07 | -0.09 | -0.16 | Upgrade
|
Filing Date Shares Outstanding | 123.55 | 105.46 | 90.73 | 60.72 | 33.99 | 19.2 | Upgrade
|
Total Common Shares Outstanding | 123.55 | 105.46 | 90.73 | 60.72 | 33.99 | 19.2 | Upgrade
|
Working Capital | -7.98 | -6.76 | -2.36 | 1.67 | -3.84 | -5.16 | Upgrade
|
Book Value Per Share | -0.07 | -0.07 | 0.03 | -0.02 | -0.13 | -0.29 | Upgrade
|
Tangible Book Value | -9.07 | -7.5 | -4.6 | -1.23 | -4.49 | -5.51 | Upgrade
|
Tangible Book Value Per Share | -0.07 | -0.07 | -0.05 | -0.02 | -0.13 | -0.29 | Upgrade
|
Machinery | - | 1.96 | 1.96 | 1.95 | 1.88 | 1.91 | Upgrade
|
Leasehold Improvements | - | 0.3 | 0.3 | 0.27 | 0.27 | 0.15 | Upgrade
|
Updated Dec 16, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.